Side-by-side comparison of AI visibility scores, market position, and capabilities
Modern cloud-native EHR for direct primary care and value-based care organizations; API-first architecture replacing legacy systems competing with athenahealth and Elation Health.
Canvas Medical is a cloud-native electronic health record (EHR) platform designed specifically for modern primary care practices — combining clinical documentation (notes, orders, prescriptions), care management (population health tracking, chronic disease programs, care gap identification), billing and revenue cycle, and patient communication in an integrated system built on a contemporary technical architecture. Founded in 2015 in San Francisco, Canvas Medical targets independent primary care practices, direct primary care (DPC) practices, and value-based care organizations frustrated with legacy EHR systems.\n\nCanvas Medical's technical approach differs from legacy EHRs (Epic, athenahealth, eClinicalWorks) which were built in the early 2000s — Canvas uses a modern, API-first architecture that makes integration with third-party tools straightforward, and its workflow design reflects current clinical practice patterns rather than 1990s paper-chart workflows. The platform is particularly popular with DPC (direct primary care) practices that operate on membership subscription models, where the EHR needs to support high-touch patient communication and proactive care rather than just fee-for-service billing. Canvas also serves value-based care organizations where population health management tools matter.\n\nIn 2025, Canvas Medical competes with athenahealth, Modernizing Medicine, Elation Health, and DrChrono for ambulatory EHR market share in the primary care segment. The EHR market is mature but experiencing disruption pressure as smaller, newer entrants offer more modern experiences to independent practices that Legacy systems with dated UX can't match. The Canvas SDK allows developers to build custom workflow integrations, positioning Canvas as a platform rather than a closed system. The 2025 strategy focuses on growing with DSC and value-based care organizations scaling their primary care networks, deepening AI-powered clinical documentation (ambient note generation), and expanding the developer ecosystem built on Canvas's open API.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.